|
nyse:snn
|
389428
|
Apr 21st, 2024 12:00AM
|
ENTrigue Surgical
|
754
|
6.00
|
Open
|
|
Apr 21st, 2024 04:35AM
|
Apr 21st, 2024 04:35AM
|
ENT, Medical Industry
|
Open
|
|
Open
|
|
|
|
US
|
|
|
Smith & Nephew
|
Health Care
|
Health Care Equipment & Services
|
|
nyse:snn
|
49990
|
Apr 21st, 2024 12:00AM
|
Osiris Therapeutics
|
9.7K
|
169.00
|
Open
|
|
Apr 21st, 2024 04:35AM
|
Apr 21st, 2024 04:35AM
|
Osiris Therapeutics, Inc. was founded in 1992 based on stem cell technology discovered by researchers at Case Western Reserve University led by Dr. Arnold Caplan. He recognized this technology had tremendous therapeutic potential.
Today, more than two decades after the journey began, Osiris continues to advance the science of cellular regenerative medicine to treat patients in need. Osiris Therapeutics, based in Columbia, Maryland, is the world leader in researching, developing and marketing regenerative medicine products. Having developed the world’s first approved stem cell drug, the company continues to advance its research and development in biotechnology by focusing on innovation in regenerative medicine – including bioengineering, stem cell research and viable tissue based products. Osiris has achieved commercial success with products in orthopaedics, sports medicine and wound care, including BIO4™, Cartiform® and Grafix®.
Osiris, Grafix, and Cartiform are registered trademarks of Osiris Therapeutics, Inc. BIO4 is a trademark of Stryker Corporation (NYSE: SYK). More information can be found on the company's website, www.Osiris.com.
|
Open
|
|
Open
|
|
|
|
US
|
|
|
Smith & Nephew
|
Health Care
|
Health Care Equipment & Services
|
|
nyse:snn
|
4789
|
Apr 21st, 2024 12:00AM
|
Smith+Nephew
|
557K
|
16781
|
Open
|
|
Apr 21st, 2024 04:35AM
|
Apr 21st, 2024 04:35AM
|
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential.
From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place.
Yes, we love to innovate and develop exciting technologies, and we offer competitive salaries and progressive benefits. But it’s our culture - of Care, Collaboration and Courage - that really sets us apart.
Through a spirit of ownership and can-do attitude, we work together to win..
We’re a company of people who care about each other, about our customers and their patients, and about our communities.
Together, we fulfill our shared purpose of Life Unlimited.
Please note: not all products referred to may be approved for use or available in all markets.
|
Open
|
healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction, sports medicine, Robotics, ENT, Trauma, hip replacement, knee replacement, extremities, Negative Pressure Wound Therapy, Ligament Repair, and Exudate Management
|
Open
|
5 Hatters Lane
|
Watford
|
Hertfordshire
|
GB
|
WD18 8YE
|
|
Smith & Nephew
|
Health Care
|
Health Care Equipment & Services
|
|
nyse:snn
|
49990
|
Apr 20th, 2024 12:00AM
|
Osiris Therapeutics
|
9.7K
|
169.00
|
Open
|
|
Apr 20th, 2024 03:36AM
|
Apr 20th, 2024 06:55PM
|
Osiris Therapeutics, Inc. was founded in 1992 based on stem cell technology discovered by researchers at Case Western Reserve University led by Dr. Arnold Caplan. He recognized this technology had tremendous therapeutic potential.
Today, more than two decades after the journey began, Osiris continues to advance the science of cellular regenerative medicine to treat patients in need. Osiris Therapeutics, based in Columbia, Maryland, is the world leader in researching, developing and marketing regenerative medicine products. Having developed the world’s first approved stem cell drug, the company continues to advance its research and development in biotechnology by focusing on innovation in regenerative medicine – including bioengineering, stem cell research and viable tissue based products. Osiris has achieved commercial success with products in orthopaedics, sports medicine and wound care, including BIO4™, Cartiform® and Grafix®.
Osiris, Grafix, and Cartiform are registered trademarks of Osiris Therapeutics, Inc. BIO4 is a trademark of Stryker Corporation (NYSE: SYK). More information can be found on the company's website, www.Osiris.com.
|
Open
|
|
Open
|
|
|
|
US
|
|
|
Smith & Nephew
|
Health Care
|
Health Care Equipment & Services
|
|
nyse:snn
|
389428
|
Apr 20th, 2024 12:00AM
|
ENTrigue Surgical
|
754
|
6.00
|
Open
|
|
Apr 20th, 2024 03:36AM
|
Apr 20th, 2024 06:55PM
|
ENT, Medical Industry
|
Open
|
|
Open
|
|
|
|
US
|
|
|
Smith & Nephew
|
Health Care
|
Health Care Equipment & Services
|
|
nyse:snn
|
4789
|
Apr 20th, 2024 12:00AM
|
Smith+Nephew
|
557K
|
16774
|
Open
|
|
Apr 20th, 2024 03:36AM
|
Apr 20th, 2024 06:55PM
|
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential.
From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place.
Yes, we love to innovate and develop exciting technologies, and we offer competitive salaries and progressive benefits. But it’s our culture - of Care, Collaboration and Courage - that really sets us apart.
Through a spirit of ownership and can-do attitude, we work together to win..
We’re a company of people who care about each other, about our customers and their patients, and about our communities.
Together, we fulfill our shared purpose of Life Unlimited.
Please note: not all products referred to may be approved for use or available in all markets.
|
Open
|
healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction, sports medicine, Robotics, ENT, Trauma, hip replacement, knee replacement, extremities, Negative Pressure Wound Therapy, Ligament Repair, and Exudate Management
|
Open
|
5 Hatters Lane
|
Watford
|
Hertfordshire
|
GB
|
WD18 8YE
|
|
Smith & Nephew
|
Health Care
|
Health Care Equipment & Services
|
|
nyse:snn
|
389428
|
Apr 19th, 2024 12:00AM
|
ENTrigue Surgical
|
754
|
6.00
|
Open
|
|
Apr 19th, 2024 05:58AM
|
Apr 19th, 2024 05:58AM
|
ENT, Medical Industry
|
Open
|
|
Open
|
|
|
|
US
|
|
|
Smith & Nephew
|
Health Care
|
Health Care Equipment & Services
|
|
nyse:snn
|
49990
|
Apr 19th, 2024 12:00AM
|
Osiris Therapeutics
|
9.7K
|
169.00
|
Open
|
|
Apr 19th, 2024 05:58AM
|
Apr 19th, 2024 05:58AM
|
Osiris Therapeutics, Inc. was founded in 1992 based on stem cell technology discovered by researchers at Case Western Reserve University led by Dr. Arnold Caplan. He recognized this technology had tremendous therapeutic potential.
Today, more than two decades after the journey began, Osiris continues to advance the science of cellular regenerative medicine to treat patients in need. Osiris Therapeutics, based in Columbia, Maryland, is the world leader in researching, developing and marketing regenerative medicine products. Having developed the world’s first approved stem cell drug, the company continues to advance its research and development in biotechnology by focusing on innovation in regenerative medicine – including bioengineering, stem cell research and viable tissue based products. Osiris has achieved commercial success with products in orthopaedics, sports medicine and wound care, including BIO4™, Cartiform® and Grafix®.
Osiris, Grafix, and Cartiform are registered trademarks of Osiris Therapeutics, Inc. BIO4 is a trademark of Stryker Corporation (NYSE: SYK). More information can be found on the company's website, www.Osiris.com.
|
Open
|
|
Open
|
|
|
|
US
|
|
|
Smith & Nephew
|
Health Care
|
Health Care Equipment & Services
|
|
nyse:snn
|
4789
|
Apr 19th, 2024 12:00AM
|
Smith+Nephew
|
557K
|
16770
|
Open
|
|
Apr 19th, 2024 05:58AM
|
Apr 19th, 2024 05:58AM
|
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential.
From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place.
Yes, we love to innovate and develop exciting technologies, and we offer competitive salaries and progressive benefits. But it’s our culture - of Care, Collaboration and Courage - that really sets us apart.
Through a spirit of ownership and can-do attitude, we work together to win..
We’re a company of people who care about each other, about our customers and their patients, and about our communities.
Together, we fulfill our shared purpose of Life Unlimited.
Please note: not all products referred to may be approved for use or available in all markets.
|
Open
|
healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction, sports medicine, Robotics, ENT, Trauma, hip replacement, knee replacement, extremities, Negative Pressure Wound Therapy, Ligament Repair, and Exudate Management
|
Open
|
5 Hatters Lane
|
Watford
|
Hertfordshire
|
GB
|
WD18 8YE
|
|
Smith & Nephew
|
Health Care
|
Health Care Equipment & Services
|
|
nyse:snn
|
49990
|
Apr 18th, 2024 12:00AM
|
Osiris Therapeutics
|
9.7K
|
169.00
|
Open
|
|
Apr 18th, 2024 04:37AM
|
Apr 18th, 2024 08:15PM
|
Osiris Therapeutics, Inc. was founded in 1992 based on stem cell technology discovered by researchers at Case Western Reserve University led by Dr. Arnold Caplan. He recognized this technology had tremendous therapeutic potential.
Today, more than two decades after the journey began, Osiris continues to advance the science of cellular regenerative medicine to treat patients in need. Osiris Therapeutics, based in Columbia, Maryland, is the world leader in researching, developing and marketing regenerative medicine products. Having developed the world’s first approved stem cell drug, the company continues to advance its research and development in biotechnology by focusing on innovation in regenerative medicine – including bioengineering, stem cell research and viable tissue based products. Osiris has achieved commercial success with products in orthopaedics, sports medicine and wound care, including BIO4™, Cartiform® and Grafix®.
Osiris, Grafix, and Cartiform are registered trademarks of Osiris Therapeutics, Inc. BIO4 is a trademark of Stryker Corporation (NYSE: SYK). More information can be found on the company's website, www.Osiris.com.
|
Open
|
|
Open
|
|
|
|
US
|
|
|
Smith & Nephew
|
Health Care
|
Health Care Equipment & Services
|